Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...
The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
New research suggests that coffee may lower the risk of AFib episodes in people who already have the condition. Cardiologists ...
August, funding lapsed for 383 studies that were testing treatments for conditions like cancer, heart disease and brain ...
A multicenter clinical trial has found that intratracheal steroids do not reduce the risk of lung disease or death in ...
OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer ...
The ongoing EPIC clinical trial is the first randomized head-to-head comparison of two neonatal Fc receptor (FcRn)-targeting ...
Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These symptoms can affect people of all ages and often include neurological ...
Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in ...
Clinical trials are more connected and more closely examined than ever. Inspection readiness isn’t a last-minute document ...
Future research should focus on implementation studies and effectiveness in clinical settings and explore the applicability of TG-iConquerFear across different cancer types,” study researchers noted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback